111 related articles for article (PubMed ID: 1187456)
1. The influence of methionine on rats and mice behaviour.
Roussinov KS; Lazarova M; Kleinrok Z; Kolasa K
Pol J Pharmacol Pharm; 1975; 27(5):535-47. PubMed ID: 1187456
[TBL] [Abstract][Full Text] [Related]
2. [Effect of aziprine on the central nervous system].
Ponomareva AG
Farmakol Toksikol; 1969; 32(4):403-6. PubMed ID: 5357457
[No Abstract] [Full Text] [Related]
3. Effects of pyrazolone-5 derivatives on amphetamine-induced hyperthermia and behavioural changes in rats.
Misterek K; Klimecka H
Pol J Pharmacol Pharm; 1976; 28(6):593-9. PubMed ID: 1034922
[No Abstract] [Full Text] [Related]
4. [Influence of methionine on the central action of tranylcypromine (author's transl)].
Wójcik E
Ann Univ Mariae Curie Sklodowska Med; 1978; 33():149-55. PubMed ID: 757925
[No Abstract] [Full Text] [Related]
5. Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system.
Sieroslawska J; Hano J; Sypniewska M; Czarnecki R; Chojnacka-Wójcik E; Harasiewicz A
Pol J Pharmacol Pharm; 1973; 25(1):1-16. PubMed ID: 4798097
[No Abstract] [Full Text] [Related]
6. Central action of pirenzepine.
Rogóz Z; Skuza G; Sowińska H
Pol J Pharmacol Pharm; 1981; 33(6):615-26. PubMed ID: 6897118
[TBL] [Abstract][Full Text] [Related]
7. The action of compound WA-335 on the central nervous system.
Maj J; Baran L; Sowińska H; Gancarczyk L
Arch Immunol Ther Exp (Warsz); 1976; 24(2):205-22. PubMed ID: 945051
[TBL] [Abstract][Full Text] [Related]
8. Comparison of central effects of noradrenaline and dopamine injected into the lateral brain ventricle in rats.
Zebrowska-Lupina I; Malec D; Kleinrok Z
Acta Physiol Pol; 1975; 26(3):261-74. PubMed ID: 1242288
[TBL] [Abstract][Full Text] [Related]
9. Psychopharmacological profile of mesterolone.
Baran L; Przegaliński E
Pol J Pharmacol Pharm; 1981 Oct; 33(3):299-303. PubMed ID: 7198778
[TBL] [Abstract][Full Text] [Related]
10. Caffeine and amphetamine produce cross-sensitization to nicotine-induced locomotor activity in mice.
Celik E; Uzbay IT; Karakas S
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):50-5. PubMed ID: 16084635
[TBL] [Abstract][Full Text] [Related]
11. The influence of a new benzonaphtyridone derivative (IFC-45) with antidepressant activity on the central nervous system. Part II. The influence on the amphetamine and reserpine effects and other pharmacological studies.
Bogdal M; Krzywosiński L; Kierylowicz H; Womela B
Pol J Pharmacol Pharm; 1975; 27(5):479-91. PubMed ID: 1187453
[TBL] [Abstract][Full Text] [Related]
12. Subchronic-intermittent caffeine amplifies the motor effects of amphetamine in rats.
Simola N; Tronci E; Pinna A; Morelli M
Amino Acids; 2006 Nov; 31(4):359-63. PubMed ID: 16874467
[TBL] [Abstract][Full Text] [Related]
13. The central action of 5-allyl-5-(beta-hydroxypropyl)-N-phenylbarbituric acid and the corresponding lactone.
Sieroslawska J; Czarnecki R; Sypniewska M; Chojnacka-Wójcik E
Pol J Pharmacol Pharm; 1973; 25(2):113-26. PubMed ID: 4798099
[No Abstract] [Full Text] [Related]
14. Effects of lithium on behaviour and central monoamines.
Engel J; Berggren U
Acta Psychiatr Scand Suppl; 1980; 280():133-43. PubMed ID: 6773300
[No Abstract] [Full Text] [Related]
15. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
16. Central action of Craviten (M-71).
Maj J; Sowińska H; Baran L; Mogilnicka E; Przewłocka B
Pol J Pharmacol Pharm; 1980; 32(6):823-32. PubMed ID: 7243679
[TBL] [Abstract][Full Text] [Related]
17. Central action of 6-hydroxytryptamine in rats.
Jamrozik-Kruk Z; Brus R
Acta Physiol Pol; 1980; 31(3):253-60. PubMed ID: 6160727
[TBL] [Abstract][Full Text] [Related]
18. Enhanced sensitivity to noradrenergic agonists and tolerance development to -methyltyrosine in the rat.
Beuthin FC; Miya TS; Blake DE; Bousquet WF
J Pharmacol Exp Ther; 1972 Jun; 181(3):446-56. PubMed ID: 5033011
[No Abstract] [Full Text] [Related]
19. [The central action of intraventricular 5-hydroxytryptamine in the rat (author's transl)].
Kleinrok Z; Jagiello-wójtowicz E
Ann Univ Mariae Curie Sklodowska Med; 1975; 30():277-83. PubMed ID: 1241762
[No Abstract] [Full Text] [Related]
20. Psychopharmacological profile of dexamisole.
Przegaliński E; Bigajska K; Siwanowicz J
Pol J Pharmacol Pharm; 1980; 32(1):21-9. PubMed ID: 7454609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
